Ionis Pharmaceuticals, Inc.
MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION

Last updated:

Abstract:

Disclosed herein are antisense compounds and methods for decreasing HBV mRNA, DNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate HBV-related diseases, disorders or conditions.

Status:
Application
Type:

Utility

Filling date:

30 Jul 2021

Issue date:

3 Mar 2022